|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Piperazine dihydrochloride | CAS 142-64-3 | ||
| C4H10N2 • 2HCl | RTECS TL4025000 | ||
|
Synonyms & Trade Names Piperazine hydrochloride [Note: The monochloride, C4H10N2 HCl, is also commercially available.] |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 5 mg/m3 | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion | ||
|
Physical Description White to cream-colored needles or powder. |
|||
|
MW: 159.1 |
BP: ? |
MLT: 635°F |
Sol: 41% |
|
VP: ? |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
| Combustible Solid, but does not ignite easily. | |||
|
Incompatibilities & Reactivities Water [Note: Slightly hygroscopic (i.e., absorbs moisture from the air).] |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, respiratory system; skin burns, sensitization; asthma; gastrointestinal upset, headache, nausea, vomiting, incoordination, muscle weakness | |
|
Target Organs
Eyes, skin, respiratory system, central nervous system |
|
| See also: INTRODUCTION |